OrbusNeich Medical Group Holdings Limited (Q8T.F)
Frankfurt · EUR · Healthcare · Medical Instruments & Supplies
€0.366 (+2.23%) as of
Key statistics
- Market cap
- 301.31M
- P/E (TTM)
- 9.15
- EPS (TTM)
- 0.0400
- Dividend yield
- 5.02%
- 52-week range
- 0.2940 – 0.4880
- Beta
- -0.58
- Revenue (TTM)
- 195.61M
- Profit margin
- 22.33%
- Volume
- 231.00
About OrbusNeich Medical Group Holdings Limited
OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents. Its product portfolio covers various treatment processes in percutaneous coronary intervention and percutaneous transluminal angioplasty procedures. It operates in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, the United States, and internationally. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Sha Tin, Hong Kong
- Employees
- 1,528
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.